Huifeng Bio-pharmaceutical Technology (fka HFGB)

[Ikem]

Dilution is priced in. I am expecting the share count to be around 50,000,000 when they are done with all the funding. Also, I am expecting revenue to triple as a result. Remember they need to raise additional capital to fund acquisition finished product factories. None of these should be news. The management has been singing this as a song as long as I can remember. This is from their presentation last march, so expect additional dilution. EPS expansion is coming in 2012.

"Additional capital injection will significantly expedite Huifeng’s growth
Target to raise $15-20M for strategic acquisition and production expansion
$5-8M is for constructing a new COS Standard API plants for disomin
$10-12M is for acquisitions of patent medicine factories"